Patents Represented by Attorney, Agent or Law Firm Richard M. Lebovitz
  • Patent number: 6801878
    Abstract: The present invention relates to systems and methods for managing sensors. In preferred embodiments of the invention, a sensor management system determines system information needs, selects one of several measurement functions capable of satisfying the system information needs, and identifies sensors to be used for performing the selected measurement function.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: October 5, 2004
    Assignee: George Mason University
    Inventors: Kenneth J. Hintz, Gregory Alan McIntyre
  • Patent number: 6635481
    Abstract: The present invention relates to all facets of a novel polynucleotide, Tbx3-pr408, the polypeptides it encodes, antibodies and specific binding partners thereto, and their applications to research, diagnosis, drug discovery, therapy, clinical medicine, forensic science and medicine, etc. The polynucleotides useful in variety of ways, including, but not limited to, as molecular markers, as drug targets, and for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, determining predisposition to, etc., diseases and conditions, such as mammary-ulnar syndrome and other developmental disorders.
    Type: Grant
    Filed: December 28, 2001
    Date of Patent: October 21, 2003
    Assignee: OriGene Technologies, Inc.
    Inventors: Zairen Sun, Wufang Fan
  • Patent number: 6518988
    Abstract: The present invention relates to various aspects of virtual manipulatives, including their use as instructional tools for building skills in mathematics. The invention also provides a system for disseminating such instructional tools on the Internet and through other connected networks.
    Type: Grant
    Filed: March 29, 1999
    Date of Patent: February 11, 2003
    Inventor: Behrouz B. Aghevli
  • Patent number: 6455292
    Abstract: The present invention relates to all facets of novel polynucleotides, the polypeptides they encode, antibodies and specific binding partners thereto, and their applications to research, diagnosis, drug discovery, therapy, clinical medicine, forensic science, pathology, and medicine. The polynucleotides are expressed in brain and pancreas and are therefore useful in variety of ways, including, but not limited to, as molecular markers, as drug targets, and for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, determining predisposition to diseases and conditions, especially relating to brain and pancreas.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: September 24, 2002
    Assignee: OriGene Technologies, Inc
    Inventors: Youmin Shu, Wufang Fan, Karl F. Kovacs, Michael Zidanic, Gilbert Jay
  • Patent number: 5504070
    Abstract: Novel and known compounds are described which inhibit endothelin converting enzyme (ECE), thereby preventing the conversion of Big Endothelin (BET) to Endothelin (ET). Pharmaceutical usefulness and preparations are described.
    Type: Grant
    Filed: December 5, 1991
    Date of Patent: April 2, 1996
    Assignee: Berlex Laboratories, Inc.
    Inventors: Ron H. Bihovsky, Paul W. Erhardt, John W. Lampe, Raju Mohan, Kenneth J. Shaw